Vibhu Parcha1, Brittain Heindl1, Rajat Kalra2, Adam Bress3, Shreya Rao4, Ambarish Pandey4, Barbara Gower5, Marguerite R Irvin6, Merry-Lynn N McDonald7, Peng Li8, Garima Arora1, Pankaj Arora1,9. 1. Division of Cardiovascular Disease (V.P., B.H., G.A., P.A.), University of Alabama at Birmingham. 2. Cardiovascular Division, University of Minnesota, Minneapolis (R.K.). 3. Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City (A.B.). 4. Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (S.R., A.P.). 5. Department of Nutrition Sciences (B.G.), University of Alabama at Birmingham. 6. Department of Epidemiology, School of Public Health (M.R.I.), Division of Pulmonary, Allergy, University of Alabama at Birmingham. 7. Critical Care (M.-L.N.M.), University of Alabama at Birmingham. 8. Department of Nursing Academic Affairs, School of Nursing (P.L.), University of Alabama at Birmingham. 9. Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).
Abstract
BACKGROUND: Black individuals have high incident diabetes risk, despite having paradoxically lower triglyceride and higher HDL (high-density lipoprotein) cholesterol levels. The basis of this is poorly understood. We evaluated the participants of SPRINT (Systolic Blood Pressure Intervention Trial) to assess the association of estimated European genetic ancestry with the risk of incident diabetes in self-identified Black individuals. METHODS: Self-identified non-Hispanic Black SPRINT participants free of diabetes at baseline were included. Black participants were stratified into tertiles (T1-T3) of European ancestry proportions estimated using 106 biallelic ancestry informative genetic markers. The multivariable-adjusted association of European ancestry proportion with indices of baseline metabolic syndrome (ie, fasting plasma glucose, triglycerides, HDL cholesterol, body mass index, and blood pressure) was assessed. Multivariable-adjusted Cox regression determined the risk of incident diabetes (fasting plasma glucose ≥126 mg/dL or self-reported diabetes treatment) across tertiles of European ancestry proportion. RESULTS: Among 2466 Black SPRINT participants, a higher European ancestry proportion was independently associated with higher baseline triglyceride and lower HDL cholesterol levels (P<0.001 for both). European ancestry proportion was not associated with baseline fasting plasma glucose, body mass index, and blood pressure (P>0.05). Compared with the first tertile, those in the second (hazard ratio, 0.64 [95% CI, 0.45-0.90]) and third tertiles (hazard ratio, 0.61 [95% CI, 0.44-0.89]) of the European ancestry proportion had a lower risk of incident diabetes. A 5% point higher European ancestry was associated with a 29% lower risk of incident diabetes (hazard ratio, 0.71 [95% CI, 0.55-0.93]). There was no evidence of a differential association between the European ancestry proportion tertiles and incident diabetes between those randomized to intensive versus standard blood pressure treatment. CONCLUSIONS: The higher risk of incident diabetes in Black individuals may have genetic determinants in addition to adverse social factors. Further research may help understand the interplay between biological and social determinants of cardiometabolic health in Black individuals. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.
BACKGROUND: Black individuals have high incident diabetes risk, despite having paradoxically lower triglyceride and higher HDL (high-density lipoprotein) cholesterol levels. The basis of this is poorly understood. We evaluated the participants of SPRINT (Systolic Blood Pressure Intervention Trial) to assess the association of estimated European genetic ancestry with the risk of incident diabetes in self-identified Black individuals. METHODS: Self-identified non-Hispanic Black SPRINT participants free of diabetes at baseline were included. Black participants were stratified into tertiles (T1-T3) of European ancestry proportions estimated using 106 biallelic ancestry informative genetic markers. The multivariable-adjusted association of European ancestry proportion with indices of baseline metabolic syndrome (ie, fasting plasma glucose, triglycerides, HDL cholesterol, body mass index, and blood pressure) was assessed. Multivariable-adjusted Cox regression determined the risk of incident diabetes (fasting plasma glucose ≥126 mg/dL or self-reported diabetes treatment) across tertiles of European ancestry proportion. RESULTS: Among 2466 Black SPRINT participants, a higher European ancestry proportion was independently associated with higher baseline triglyceride and lower HDL cholesterol levels (P<0.001 for both). European ancestry proportion was not associated with baseline fasting plasma glucose, body mass index, and blood pressure (P>0.05). Compared with the first tertile, those in the second (hazard ratio, 0.64 [95% CI, 0.45-0.90]) and third tertiles (hazard ratio, 0.61 [95% CI, 0.44-0.89]) of the European ancestry proportion had a lower risk of incident diabetes. A 5% point higher European ancestry was associated with a 29% lower risk of incident diabetes (hazard ratio, 0.71 [95% CI, 0.55-0.93]). There was no evidence of a differential association between the European ancestry proportion tertiles and incident diabetes between those randomized to intensive versus standard blood pressure treatment. CONCLUSIONS: The higher risk of incident diabetes in Black individuals may have genetic determinants in addition to adverse social factors. Further research may help understand the interplay between biological and social determinants of cardiometabolic health in Black individuals. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.
Entities:
Keywords:
blood pressure; continental population groups; diabetes mellitus; ethnic and racial minorities; genetics; metabolic syndrome; social factors
Authors: E Ramos; G Chen; D Shriner; A Doumatey; N P Gerry; A Herbert; H Huang; J Zhou; M F Christman; A Adeyemo; C Rotimi Journal: Diabetologia Date: 2010-12-25 Impact factor: 10.122
Authors: Linda S Geiss; Jing Wang; Yiling J Cheng; Theodore J Thompson; Lawrence Barker; Yanfeng Li; Ann L Albright; Edward W Gregg Journal: JAMA Date: 2014-09-24 Impact factor: 56.272
Authors: Shreya Rao; Matthew W Segar; Adam P Bress; Pankaj Arora; Wanpen Vongpatanasin; Vijay Agusala; Utibe R Essien; Adolfo Correa; Alanna A Morris; James A de Lemos; Ambarish Pandey Journal: JAMA Cardiol Date: 2020-11-13 Impact factor: 14.676
Authors: Nisa M Maruthur; W H Linda Kao; Jeanne M Clark; Frederick L Brancati; Ching-Yu Cheng; James S Pankow; Elizabeth Selvin Journal: Diabetes Date: 2011-07-25 Impact factor: 9.461
Authors: M Sue Kirkman; Vanessa Jones Briscoe; Nathaniel Clark; Hermes Florez; Linda B Haas; Jeffrey B Halter; Elbert S Huang; Mary T Korytkowski; Medha N Munshi; Peggy Soule Odegard; Richard E Pratley; Carrie S Swift Journal: Diabetes Care Date: 2012-10-25 Impact factor: 19.112
Authors: Christina L Wassel Fyr; Alka M Kanaya; Steve R Cummings; David Reich; Wen-Chi Hsueh; Alexander P Reiner; Tamara B Harris; Susan Moffett; Rongling Li; Jingzhong Ding; Iva Miljkovic-Gacic; Elad Ziv Journal: Hum Genet Date: 2007-03-28 Impact factor: 5.881